title: Atovaquone-proguanil use in early pregnancy and the risk of birth defects.
authors.forename: Björn
authors.initials: B
authors.lastname: Pasternak
authors.forename: Anders
authors.initials: A
authors.lastname: Hviid
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D000962:Antimalarials / Q000008:administration & dosage / Q000633:toxicity*; D053626:Atovaquone / Q000008:administration & dosage / Q000633:toxicity*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D003718:Denmark; D004338:Drug Combinations; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008288:Malaria / Q000517:prevention & control*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control*; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data; D002727:Proguanil / Q000008:administration & dosage / Q000633:toxicity*; D012042:Registries / Q000706:statistics & numerical data
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C109496:atovaquone, proguanil drug combination; D002727:Proguanil; D053626:Atovaquone